Ophthalmic Devices: Rayner Intraocular Lenses Limited

• Publication date: June 2012
• Report size: 33 pages

This report is a source for data, analysis and actionable intelligence on the Rayner Intraocular Lenses Limited portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover data on product desc...

This report is a source for data, analysis and actionable intelligence on the Rayner Intraocular Lenses Limited portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover data on product description, function, technology, indication, and application. The report is also supplemented with a detailed industry player profile and data on clinical trials, wherever applicable.

Scope of the Research

- Detailed industry player profile with data on business description, key industry player facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the new product development, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional data on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with data on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, industry ing and sales strategies.
- Exploit Merger and Acquisition opportunities by identifying industry players with the most innovative pipeline.
- Develop successful market-entry strategies .
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ new product development through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

Ophthalmic Devices Industry

Data table of Contents
Data table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Rayner Intraocular Lenses Limited - Major Products and Services 5
Rayner Intraocular Lenses Limited Pipeline Products by Equipment Type 6
Rayner Intraocular Lenses Limited Pipeline Products by Development Stage 7
Rayner Intraocular Lenses Limited Pipeline Products by Therapy Area 8
Superflex 620H IOL 10
Product Status 10
Product Description 10
Superflex 620H IOL Clinical Trial 10
Superflex 920H Aspheric 11
Product Status 11
Product Description 11
Rayner Intraocular Lenses Limited - Top Competitors 12
Rayner Intraocular Lenses Limited - Operations and Subsidiaries 13
Head Office 13
Appendix 14
Methodology 14
About GlobalData 14
Contact Us 14
Disclaimer 14


List of Tables

Rayner Intraocular Lenses Limited, Major development 1
Rayner Intraocular Lenses Limited Key Pipeline Products by Equipment Type 1
Rayner Intraocular Lenses Limited Key Pipeline Products by Therapy Area 1
Rayner Intraocular Lenses Limited Key Pipeline Products by Development Stage 1
Rayner Intraocular Lenses Limited Key Pipeline Products by Trial Phase 1
Rayner Intraocular Lenses Limited, Major development 4
Rayner Intraocular Lenses Limited, Major Products and Services 5
Rayner Intraocular Lenses Limited Number of Pipeline Products by Equipment Type 6
Rayner Intraocular Lenses Limited Pipeline Products by Equipment Type 6
Rayner Intraocular Lenses Limited Number of Pipeline Products by Development Stage 7
Rayner Intraocular Lenses Limited Pipeline Products by Development Stage 7
Rayner Intraocular Lenses Limited Number of Pipeline Products by Therapy Area 8
Rayner Intraocular Lenses Limited Pipeline Products by Therapy Area 8
Rayner Intraocular Lenses Limited Pipeline Products by Trial Phase 9
Superflex 620H IOL - Product Status 10
Superflex 620H IOL - Product Description 10
Superflex 620H IOL - Capsule Biocompatibility with a 6.25mm optic Lens in High Myopic Eyes. 10
Superflex 920H Aspheric - Product Status 11
Superflex 920H Aspheric - Product Description 11


List of Figures

Rayner Intraocular Lenses Limited Pipeline Products by Equipment Type 6
Rayner Intraocular Lenses Limited Pipeline Products by Development Stage 7
Rayner Intraocular Lenses Limited Pipeline Products by Therapy Area 8

Companies mentioned TEKIA, Inc.
Lenstec, Inc.
Contamac Ltd
Catatrac Ltd